Search results
Results from the WOW.Com Content Network
The basilic vein is a large superficial vein of the upper limb that helps drain parts of the hand and forearm. [1] It originates on the medial side of the dorsal venous network of the hand and travels up the base of the forearm, where its course is generally visible through the skin as it travels in the subcutaneous fat and fascia lying superficial to the muscles.
In human anatomy, the median cubital vein (or median basilic vein) is a superficial vein of the arm on the anterior aspect of the elbow. It classically shunts blood from the cephalic to the basilic vein at the roof of the cubital fossa. It is typically the most prominent superficial vein in the human body, and is visible when all other veins ...
The veins of the arm carry blood from the extremities of the limb, as well as drain the arm itself. The two main veins are the basilic and the cephalic veins. There is a connecting vein between the two, the median cubital vein, which passes through the cubital fossa and is clinically important for venepuncture (withdrawing blood). The basilic ...
The subclavian vein is a big vessel that drains the blood from the hand, forearm and the upper arm into the right side of the heart through superior vena cava. The subclavian veins lie just behind the clavicle on each side and therefore known as subclavian vein. [citation needed]
In human anatomy, the cephalic vein (also called the antecubital vein) [1] is a superficial vein in the arm. It is the longest vein of the upper limb. It starts at the anatomical snuffbox from the radial end of the dorsal venous network of hand, and ascends along the radial (lateral) side of the arm before emptying into the axillary vein.
The median cubital vein, which lies within the cubital fossa anterior to the elbow, is close to the surface of the skin without many large nerves positioned nearby. Other veins that can be used in the cubital fossa for venipuncture include the cephalic, basilic, and median antebrachial veins. [4]
Prosthetic heart valves, including the Hancock Aortic Tissue Valve, are not without drawbacks. Structural degradation is a risk, potentially necessitating reoperation. [ 13 ] [ 3 ] Studies have indicated the need for ongoing research and improvement in bioprosthetic valve technology to address such concerns [ 13 ]
The ATS Open Pivot Heart Valve was first sold in international markets in 1992 and subsequently granted FDA clearance to sell in the United States in 2000. To date more than 140,000 valves have been implanted worldwide. The company subsequently developed a more diversified cardiac surgery business offering several categories of products: